Chief Executive Special Series: 26 October – Dr Cameron Wolfe COVID-19 Q&A Sessions Video 6

Special Series: Dr Cameron Wolfe COVID-19 Q&A sessions 

Dr Cameron Wolfe details the evidence that there is no reason to expect mid-to-long term negative effects from vaccination

We wrap up our Special Series with Dr Cameron Wolfe with the sixth and final video, addressing one of the most common questions about COVID-19 vaccination; “How do I know there won’t be any negative long-term impacts?”.

Cameron discusses COVID-19 vaccination’s medium-to-long effects following his close involvement in the research phase, including being one of the first to receive the Pfizer vaccine in 2020 as part of initial clinical trials.

In addition to firsthand experience with the vaccine trials, Cameron and his team have benefited from learning through clinical interactions caring for COVID-positive patients at Duke University Hospital. They have observed the safe and effective protection afforded to their workforce and the community by the vaccine.

At peak times, coping with upwards of 200 admissions a day, they have observed 92 per cent of those hospitalised are yet to be vaccinated. Of the remaining eight per cent, the majority are immunocompromised, which means a weakened response to vaccination, not an unwillingness to be vaccinated.

Cameron’s is a reassuring and credible voice for anyone who has wanted to know more about the vaccine’s longer-term effects and provides valuable information to share with others about the safety and efficacy of vaccination.

Please take a moment to watch the video and, as we conclude our Special Series of Q&A videos, I want to thank you all for your interest in the topics covered with Cameron.

Further Special Series will go in-depth into various topics in the coming months, and I look forward to sharing these with you.

Thank you for your support and commitment to continuous learning and improving our community’s healthcare outcomes.

Andrew Stripp
Chief Executive